Tech Company Financing Transactions
X4 Pharmaceuticals Funding Round
X4 Pharmaceuticals closed a $25.8 million financing round on 11/16/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
11/16/2017
Transaction Type
Venture Equity
Amount
$25,838,812
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 213 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
955 Massachusetts Ave. 4th Floor 140
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and increase the ability for T-Cells to track and destroy cancer cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paula Ragan
Chief Financial Officer
Adam Mostafa
Chief Medical Officer
Kenneth Gorelick
VP - Human Resources
Ronny Mosston
VP - Operations
Mary DiBiase
VP - Operations
Celeste DiJohnson
VP - Regulatory Affairs
Tarek Ebrahim
Browse more venture capital transactions:
Prev: 11/16/2017: CY Vision venture capital transaction
Next: 11/16/2017: Nudge Rewards venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs